HANCOCK WHITNEY CORP - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
HANCOCK WHITNEY CORP ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,211,000
+17.1%
125,0000.0%0.04%
+11.4%
Q1 2021$1,034,000
+20.8%
125,000
-0.3%
0.04%
+20.7%
Q4 2020$856,000
-42.3%
125,382
-5.7%
0.03%
-47.3%
Q3 2020$1,483,000
+38.7%
132,978
-21.9%
0.06%
+34.1%
Q2 2020$1,069,000170,2400.04%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,623,533$22,851,0006.45%
Avoro Capital Advisors LLC 1,146,579$9,987,0003.44%
Cormorant Asset Management, LP 2,095,334$18,250,0002.18%
Healthcare Value Capital, LLC 50,000$436,0000.72%
CAPITAL MANAGEMENT ASSOCIATES /NY/ 20,000$174,0000.25%
SABBY MANAGEMENT, LLC 300,000$2,613,0000.14%
STRATEGIC INVESTMENT MANAGEMENT, LLC 20,398$177,0000.10%
Granite Investment Partners, LLC 89,622$781,0000.07%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 54,634$476,0000.06%
Trexquant Investment LP 67,929$592,0000.05%
View complete list of SORRENTO THERAPEUTICS INC shareholders